Partneringreview 2006 – Industry sector Discovery provides an in depth view into the drug discovery deals and alliances announced in 2005, in a clear and accessible format.
The report analyzes deals announced by company, industry focus, and therapy focus. Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed.
Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report. When using the PDF format in Acrobat Reader, simply click on the number to move around the report.
Other selected research from the 'Business Development' category:
Financial Deals Industry Tracker: Pharmaceuticals and Healthcare July 2008
Analysis and opinion on monthly deal activity, along with the trend for the last six months for merger and acquisition (M&A), private equity, private placement, IPO, and secondary offering deals. Learn More
Enabling Translational Medicine with BI (Technology Focus)
This brief offers an analysis of the technology components that will enable translational research in the pharmaceutical industry. Learn More
Other selected research from the 'Drug Discovery' category:
Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition
Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical market grows, so should interest in the cell culture products market. Biopharmaceutical products are developed... Learn More
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition
Kalorama Information’s Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market... Learn More